Wolverine Trading
NAUT icon

Wolverine Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Wolverine Trading’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-26,100
Closed -$140K – 6099
2021
Q4 		$140K Buy
+26,100
New +$140K ﹤0.01% 4926

Other funds holding NAUT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
AEPLI
AH Equity Partners LSV II Menlo Park, California $95.6M AUM 8.86% 1-Year Est. Return

Wolverine Trading's NAUT Position: Q2 2023 in Review

Wolverine Trading sold out of Nautilus Biotechnolgy (NAUT) in Q2 2023, closing a stake of 32,326 shares — an estimated $85K sold.

Wolverine Trading first reported a position in NAUT in Q1 2023 and held it in 1 quarter. The position peaked at $85K in Q1 2023. 75 funds tracked by Wall St. Rank hold NAUT as of Q2 2023.

  • Wolverine Trading reported no remaining Nautilus Biotechnolgy position as of Q2 2023 after selling out during the quarter.
  • Wolverine Trading sold 32,326 Nautilus Biotechnolgy shares in Q2 2023, an estimated $85K.
  • Wolverine Trading first reported a position in Nautilus Biotechnolgy in Q1 2023 and held it in 1 quarter.
  • Wolverine Trading's Nautilus Biotechnolgy position peaked at $85K in Q1 2023.
  • 75 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2023.

Based on Wolverine Trading's 13F filing for Q2 2023, filed 23 Aug 2023.